110 likes | 117 Views
Read here the latest updates on the Tylosin Market Analysis published by CMI team
E N D
Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker
TYLOSIN MARKET ANALYSIS • Tylosin Market, by Drug Type (Tylosin Phosphate, Tylosin Tartrate, and Others), by Application (Felines, Canines, and Livestock), by Route of Administration (Oral and Injectable), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast to 2026 • The global Tylosin market size was valued at US$ 379.0 million in 2017, and is expected to witness a CAGR of 1.2% over the forecast period (2018 – 2026).
Market Drivers • Continuous demand for tylosin in livestock industry is expected to propel growth of the global Tylosin Market over the forecast period • Antimicrobial medications are generally used in the livestock industry for treatment of various infections in the livestock, prevention of disease, and to improve growth rate of the animals efficiency. Moreover, antimicrobial medications have been found to be effective in animals for improving growth rate and increasing weight more efficiently, which in turn results in increasing profits for the meat producers. • According to National Center for Biotechnology Information (NCBI), 2015, around 80% of antibiotics sold in the U.S. are for animal agriculture and almost 70% of these are medically important (i.e. from classes’ important to human medicine). Moreover, according to NCBI, the antimicrobial consumption in livestock is expected to increase by 67% by 2030, and nearly double in Brazil, Russia, India, China, and South Africa. These factors are expected to boost the global Tylosin market growth over the forecast period. • Rising income levels and disposable income in emerging economies such as Asia-Pacific has caused increase in demand for healthy protein sources for consumption as daily protein need of the body is not met through conventional food sources. According to NCBI, 2015, in Asia, the daily animal protein intake increased from 7 grams per capita per day to 25 grams per capita per day between 1960, and 2013. Countries such as Brazil, Russia, India, China, and South Africa (BRICS) have started implementing intensive livestock production systems to meet this demand (which necessitates use of antimicrobials). These factors are expected to support growth of the global Tylosin market over the forecast period.
Increasing demand for healthy livestock is expected to support growth of global Tylosin market over the forecast period • The demand for livestock animals for consumption is on the rise worldwide and is expected to maintain the positive growth in demand over the forecast period. Subsequently, the demand for infection-free and healthy livestock used primarily for consumption is increasing. However, the prevalence of various microbial infections is high in both humans and animals. For instance, according to the Centers for Disease Control and Prevention (CDC), 2017, zoonotic diseases are common in the U.S. and worldwide and over 6 out of every 10 known infectious diseases in humans are spread from animals. Hence, antibiotics are an important medication for livestock that aide in providing healthy food products for consumption in humans. • Moreover, antibiotics such as Tylosin are used in various animal species for prevention of mycoplasmosis. For instance, animals such as chickens, turkeys, pigs, and calves require oral Tylosin to be administered in required dosage to prevent mycoplasmosis and to grow healthy livestock. Furthermore, livestock is a major source of income in several of the emerging economies such as Brazil, which is major factor expected to contribute in growth of the market in the region over the forecast period.
Market Restraint • However, increasing antimicrobial resistance in livestock is expected to restrain growth of the global Tylosin market over the forecast period. For instance, in 2013, University of California, San Francisco (UCSF) Academic Senate passed a resolution to restrict purchase of meat raised with nontherapeutic antibiotics.
Key Players • Key players operating in the global Tylosin market include Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare Pharma, and Elanco Animal Health.
Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Reference : https://www.coherentmarketinsights.com/market-insight/tylosin-market-2061
About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis
Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/